Secondary Logo

Journal Logo

You can read the full text of this article if you:

Institutional members access full text with Ovid®

Clinical Studies

Sequential Administration of the Native TERT572 Cryptic Peptide Enhances the Immune Response Initiated by its Optimized Variant TERT572Y in Cancer Patients

Vetsika, Eleni-Kyriaki*; Papadimitraki, Elisavet*; Aggouraki, Despoina*; Konsolakis, Georgios*; Mela, Marina-Eleni*; Kotsakis, Athanasios; Christou, Soultana; Patramani, Stefania; Alefantinou, Marina; Kaskara, Ageliki; Christophyllakis, Charalampos; Kosmatopoulos, Kostas§; Georgoulias, Vassilis*,†,‡; Mavroudis, Dimitris*,†

Author Information
doi: 10.1097/CJI.0b013e31823284a6
  • Buy
  • SDC

© 2011 Lippincott Williams & Wilkins, Inc.